Nearly 5 million people have tested positive for COVID-19 and 323,000 have died. With new symptoms and complications arising, and a lack of verified treatment, physicians and scientists are puzzled and frustrated. Why are some adult patients developing respiratory failure with ARDS while others are struck with systemic vasculitis with resultant thrombosis (blood clots) and resultant heart attacks and strokes? Additionally, despite early expectations that children were not at particular risk for COVID-19, recent reports from Europe and New York indicate that school-aged children and teenagers are developing a rapidly declining life-threatening complication referred to as Kawasaki-Like Syndrome or Multisystem Inflammatory Syndrome in Children (MIS-C), also with vasculitis and cardiac involvement. Some have proposed that the link between vasculitis in the pediatric and adult population seems to be autoimmune, or a self-attack of the immune system, but why? What is the best form of prevention and treatment...